glp-1 for autoimmune inflammation Can Drugs Boost Immunity? Glucagon-like peptide and its receptor

Although these agents produce substantial and sustained weight reduction, emerging clinical observations suggest that chronic therapy may be accompanied by changes in lean mass trajectory, reduced protein intake, and micronutrient insufficiency

Phase Angle Phase Angle A marker of cellular health and membrane integrity

Longer life expectancy with less risk of premature death from heart disease, stroke, diabetes, and other obesity-related conditions

This suggests that nutrient-induced GLP-1 secretion was inhibited by pasireotide via SSTR-Gi-dependent inhibition of cAMP levels

[DOI] [PMC free article] [PubMed] [Google Scholar] 80.Nasteska D, et al